Report on Re-lodgement of Physical Share Transfer Requests
This is a standard compliance update with no significant impact on the company's operations or financials.
The announcement is a routine regulatory filing regarding share transfer requests, with no indication of positive or negative impact.
* Vivimed Labs Limited has submitted a report from their Registrar and Share Transfer Agent, Aarthi Consultants Pvt Ltd, regarding the re-lodgement of transfer requests for physical shares. * The report, dated 10 September 2025, is in compliance with SEBI circular SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated 2 July 2025. * As of August 2025, no requests were received, processed, approved, or rejected during the month. The average time taken for processing requests was NIL.
What to do with a filing like this
Vivimed Labs Limited filed this with the NSE as a statutory disclosure, categorised under regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vivimed Labs Limited. Read the original for the full detail.